Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Stryker CorporationNYSE: SYK

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 68.3%

Gross margin was 68.3% in Q2 FY2026, up 3.3 pp from a year earlier. On a trailing-twelve-month basis it was 65.2%, up 2.3 pp year over year. Over 3 fiscal years it widened by 4.1 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
68.3%+5.0 pp QoQ
Last fiscal yearDec 2025
64.0%-0.4 pp YoY
LTMJun 2026
65.2%+2.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.3 pp——
1 year-0.4 pp——
3 years+4.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
64.0%
Year-over-year change
-0.4pp

Gross Margin vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's LTM Jun 2026 gross margin of 65.2% is the 7th highest of the 11 companies compared; the peer median is 66.0%.
  • Its year-over-year change of +2.3 pp is the 4th highest of 11, against a peer median of -0.0 pp.
  • Over three fiscal years its change of +4.1 pp compares with a peer median of -2.3 pp.
SYK Competitors Peer median
Gross Margin for SYK and competitors
Company Period LTM level YoY 3-year change
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202669.9% -1.2 pp-9.3 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
GMEDGlobus Medical, Inc.LTM Jun 202668.5% +5.8 pp-6.8 pp
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 202662.3% +4.2 pp+7.5 pp
ENOVEnovis CorporationLTM Apr 202656.8% +0.3 pp+4.2 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
Peer median (excluding SYK) 66.0%-0.0 pp-2.3 pp

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.11B18.45B20.5B22.6B25.12B
Cost of Revenue6.4B7.41B8B8.05B9.05B
Gross Profit10.71B11.04B12.49B14.55B16.07B
Gross Margin62.6%59.8%61.0%64.4%64.0%
Research & Development1.13B1.23B1.29B1.47B1.58B
Selling, General & Admin5.81B6.08B6.92B7.5B8.65B
Operating Expenses6.95B7.31B8.21B10.86B11.18B
Depreciation & Amortization990M998M1.03B1.05B1.19B
EBITDA3.61B4.02B5.06B6.01B6.31B
EBITDA Margin21.1%21.8%24.7%26.6%25.1%
Operating Income3.76B3.73B4.28B3.69B4.89B
Operating Margin22.0%20.2%20.9%16.3%19.5%
Interest Income68M94M75M139M121M
Interest Expense337M337M356M396M607M
Other Income / Expenses(1.48B)(1.05B)(608M)(197M)(375M)
Income Before Tax2.28B2.68B3.67B3.49B4.51B
Pre-Tax Margin13.3%14.5%17.9%15.5%18.0%
Income Tax Expense287M325M508M499M1.27B
Net Income1.99B2.36B3.17B2.99B3.25B
Net Margin11.7%12.8%15.4%13.2%12.9%
EPS (Basic)5.296.238.347.868.49
EPS (Diluted)5.226.178.257.768.40
Weighted Avg Shares377M378.2M379.6M381M382.2M
Weighted Avg Shares (Diluted)382.3M382.2M383.7M385.6M382.2M

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.